Sareum - Specialists in Cancer Drug Discovery
Print the page Smaller text Larger text

 

Result of AGM
14 December, 2011

Sareum to Present at International Conference
11 November, 2011

Report & Accounts & Notice of AGM Available
04 November, 2011

Final Results
26 September, 2011

Sareum to Present at European Cancer Conference
14 September, 2011

RSS news feed News feed
requires RSS news reader

Sareum Holdings
Last Trading 1.20
Trade Time 16:24am
Change 0.00
Open 1.22
Day's Range 1.103 - 1.25
Volume 6507764

 

Sareum's small molecule drug discovery expertise is building value by developing oncology drug candidates for licencing to pharmaceutical and biotechnology companies

Providing protein structure-based research services to accelerate customers’ drug discovery programmes
Developing oncology drug candidates for licensing to pharmaceutical companies
Learn more about Sareum’s pre-clinical oncology pipeline of targeted small molecule drug candidates
Sareum Holdings Plc's house broker, Hybridan LLP, will from time to time publish research notes on the Company. You can download the research notes from this page. (Latest update: Jan 2012).
 
2011 Annual Report & Accounts is available for download here:
  Annual Report 2011
 
 
Website last updated on: 19-January-2012
 


Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader


site map

email: info@sareum.co.uk tel: +44 (0) 1223 497700 fax: +44 (0) 1223 497701